Loading...
XTAI
4164
Market cap176mUSD
Jul 09, Last price  
29.00TWD
1D
0.17%
1Q
-7.94%
Jan 2017
-33.79%
IPO
-79.68%
Name

CHC Healthcare Group

Chart & Performance

D1W1MN
XTAI:4164 chart
P/E
30.41
P/S
1.29
EPS
0.95
Div Yield, %
4.68%
Shrs. gr., 5y
2.32%
Rev. gr., 5y
11.48%
Revenues
4.40b
+22.15%
170,398,0001,867,510,0001,995,368,0001,989,670,0002,062,991,0002,091,026,0002,395,331,0002,205,206,0002,117,116,0002,507,466,0002,950,052,0002,554,911,0002,439,564,0002,974,352,0003,877,137,0003,600,574,0004,398,280,000
Net income
186m
+10.63%
6,299,000483,548,000583,450,000430,685,000296,862,000265,766,000226,518,000158,932,000-86,695,000323,422,000395,172,000366,389,000381,633,000356,571,000418,866,000168,384,000186,277,000
CFO
1.03b
+934.64%
-61,917,000510,142,000477,215,000295,942,000869,311,000634,233,000504,900,0001,137,168,000293,816,000390,688,0001,189,693,000915,465,000692,795,000656,659,000962,588,00099,367,0001,028,093,000
Dividend
Jun 26, 20251.35676 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Taipei, Taiwan, in 1977, the CHC Healthcare Group delivers a wide array of healthcare management services both within Taiwan and globally. Its core activities involve the distribution, installation, maintenance, and leasing of medical equipment. Furthermore, the company extends its expertise to include business management consulting, educational programs, elder care provisions, and radiation sterilization operations. The specialized equipment it provides serves key medical fields such as radiation oncology, neurology, medical imaging, ophthalmology, and surgery.
IPO date
Oct 18, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT